Compare and analyse stocks of the biotech and pharma sector based on performance indicators and features. In addition, a peer group analysis is available comparing price and volume features to all other available listed companies is available. This free stock comparison tool provides insights into price performance, volatility, relative volume, RSI, MFI, distance to minimum and relative position across this biopharma sector. Biotech and pharma is made up of a diverse set of companies as not only pharmaceuticals are included, but also vaccines, healthcare products and active ingredients. The organisations themselves can be promising in delivering new products or very well-established and being active in taking over smaller players. Many companies have a diversified portfolio, often including consumer health care products.
For a selection of listed companies, a deeper technical analysis is available, focussing more in detail on changes in price and volume over time. For the biotech and pharma sector these are: AbbVie, Eli Lilly, Johnson & Johnson, Merck, Novartis, Pfizer, Qiagen, Roche and Sanofi.
Categories of available biopharma sector analysis charts:
• Key features
• Sector performance overview
• Performance insights
• Trading opportunities
• Understanding risk
• Peer comparison
Key Biopharma Features – the main indicator values of individual shares used in the analysis [guide]
| Company | StockMarket | Close | Price-1m | Price-3m | Volume-1m | Volatility-1m | Volatility-3m | RSI-14 | MFI |
|---|---|---|---|---|---|---|---|---|---|
| Eurofins Scientific | CAC | 55.30 | 5.5 | 16.0 | 98.1 | 3.0 | 4.3 | 35.0 | 47.8 |
| Sanofi CAC | CAC | 100.34 | -2.9 | 8.6 | 97.8 | 1.3 | 4.1 | 39.5 | 53.7 |
| Bayer | DAX | 26.53 | -0.7 | 0.5 | 94.6 | 5.1 | 4.6 | 11.2 | 5.5 |
| Merck | DAX | 156.95 | -5.5 | 3.4 | 94.6 | 2.7 | 4.5 | 46.4 | 46.0 |
| Qiagen | DAX | 40.54 | -2.9 | 6.1 | 76.5 | 1.6 | 2.8 | 51.3 | 60.8 |
| Sartorius | DAX | 185.60 | -1.5 | -3.2 | 79.1 | 3.0 | 3.5 | 23.4 | 10.3 |
| Alcon | SMI | 84.10 | 0.9 | 4.2 | 66.5 | 1.0 | 2.1 | 48.1 | 63.9 |
| Lonza Group | SMI | 539.20 | -2.1 | 4.5 | 59.4 | 1.2 | 3.1 | 54.5 | 55.5 |
| Novartis | SMI | 100.32 | 1.9 | 1.2 | 90.7 | 1.0 | 2.0 | 79.4 | 68.7 |
| Roche | SMI | 271.10 | 2.7 | 4.8 | 92.5 | 1.4 | 3.0 | 51.0 | 53.4 |
| Amgen | Dow Jones | 326.06 | -2.7 | -1.2 | 79.9 | 2.3 | 1.9 | 56.9 | 45.3 |
| Johnson & Johnson | Dow Jones | 164.83 | -1.3 | 10.4 | 78.8 | 1.4 | 2.4 | 67.1 | 52.9 |
| Merck | Dow Jones | 111.34 | -5.6 | -13.1 | 107.0 | 3.0 | 4.3 | 40.8 | 37.2 |
| Abbott Laboratories | S&P100 | 117.35 | -0.2 | 14.0 | 80.2 | 1.6 | 3.9 | 71.6 | 74.5 |
| AbbVie | S&P100 | 194.86 | -0.4 | 16.0 | 80.7 | 0.8 | 4.1 | 35.5 | 46.0 |
| Bristol-Myers Squibb | S&P100 | 53.12 | 6.3 | 32.3 | 84.4 | 3.3 | 6.3 | 61.5 | 65.0 |
| Eli Lilly | S&P100 | 912.52 | -1.2 | -4.0 | 85.4 | 1.8 | 5.5 | 63.6 | 70.1 |
| Gilead Sciences | S&P100 | 86.26 | 3.7 | 21.8 | 94.9 | 1.2 | 5.8 | 67.8 | 62.1 |
| Pfizer | S&P100 | 29.64 | -1.4 | 1.8 | 77.9 | 1.7 | 2.3 | 58.4 | 40.6 |
| AstraZeneca | NASDAQ | 77.83 | -1.5 | -0.4 | 65.2 | 1.0 | 4.1 | 49.4 | 51.6 |
| Biogen | NASDAQ | 192.65 | -3.5 | -13.1 | 116.2 | 2.9 | 5.7 | 47.5 | 37.6 |
| Dexcom | NASDAQ | 67.97 | -3.0 | -39.9 | 102.3 | 2.2 | 19.5 | 55.1 | 59.8 |
| Idexx laboratories | NASDAQ | 481.99 | -5.7 | -0.1 | 79.3 | 3.3 | 2.9 | 25.2 | 43.5 |
| Moderna | NASDAQ | 57.53 | -16.8 | -52.6 | 111.2 | 7.0 | 25.7 | 14.7 | 26.2 |
| Regeneron Pharmaceuticals | NASDAQ | 1,019.28 | -11.6 | -5.8 | 135.7 | 5.2 | 5.7 | 35.2 | 36.0 |
| Vertex Pharmaceuticals | NASDAQ | 483.13 | -1.3 | -1.6 | 79.8 | 2.4 | 2.7 | 63.4 | 65.0 |
Sector Performance Overview – recent behaviour of a stock using trading activity and results [guide]
Performance Insights – combine stock features to understand their connection [guide]
Trading Opportunities Biopharma – guidance to identify which shares could be of interest to buy or sell [guide]
Understanding Risk – recent fluctuations and movements that indicate potential price changes [guide]
Peer Comparison – Compare the performance of the biopharma sector to all stocks [guide]
Useful resources
Stocoto.com provides a tool to obtain more insights into stock performance, opportunity and risk. Stocoto.com does not give advice. It is advised to use additional resources to make informed decisions. It is the decision of the user to buy or sell a stock. The price of a stock can increase or decrease.